Latest Rhinitis Stories
MISSISSAUGA, ON and MONTREAL, QC, June 17, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, and Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company today announced that they have amended their loan arrangements (the "Loan") originally agreed to in May 2012. In May of 2012, Nuvo...
MONTREAL, May 21, 2013 /CNW Telbec/ - A national survey conducted by Léger Marketing highlights that one quarter of Canadians who suffer from allergies will wait until their symptoms become unbearable before seeking treatment, while half of Canadians will wait up to 24 hours before seeking relief. The survey also shows that 17% of Canadians do not seek any treatment, choosing instead to tolerate their discomfort. The survey, conducted by Leger on behalf of Merck, manufacturer...
Combined Epocrates and athenahealth Data Reveals Midwest and Northeast are Late Bloomers San Mateo, CA (PRWEB) May 16, 2013 WATERTOWN, MA - May 16, 2013 – Seasonal allergies are still on the rise this year, according to new data compiled from Epocrates and athenahealth. Allergy Season 2013 has yet to reach a peak, whereas by this time last year, the number of patients across the country seeking medical treatment for allergies was starting to decline. “The worst may still be coming for...
MISSISSAUGA, ON, May 14, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that the United States Patent Office has granted U.S. Patent # 8,435,568, relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis...
New Survey Reveals the Impact of Nasal Allergies on Sleep, Relationships and Productivity LANDOVER, Md., April 23, 2013 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory released results today from a new survey which showed that more than half (59 percent) of nasal allergy sufferers polled reported sleep issues as a result of their allergy symptoms, yet only 35 percent proactively treat their nasal allergy symptoms. Furthermore, nearly half of...
-Indicated for seasonal & perennial allergic rhinitis in children ages 2 and up MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Karbinal(TM) ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor...
Lifetime Health Australia reminds seasonal allergy sufferers that natural relief may be at hand with Quercetin - a natural antihistamine found in a range of foods and health supplements. Sydney, NSW (PRWEB) March 14, 2013 Quercetin is thought to be a useful natural defense against allergic reactions as it demonstrates both anti-histamine and anti-inflammatory activity. Quercetin is often referred to as a ‘natural antihistamine’ as it is thought to minimize the release of histamine...
CHICAGO, Jan. 30, 2013 /PRNewswire/ -- Seasonal allergies are somewhat predictable and each year the media is quick to point out pollen count peaks. But how much do you know about your own personal allergen triggers? According to Chicago allergist Dr. Brian Rotskoff of Clarity Allergy Center, you can significantly improve your quality of life by learning about and preparing for your own "high-sneeze, high-itch" months. Not only will your nose feel better, controlling the symptoms of...
“Seasonal Allergic Rhinitis – Pipeline Review, H2 2012” & “Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H2 2012” are the latest reports added to online market research library of RnRMarketResearch.com Dallas, Texas (PRWEB) January 01, 2013 This report provides information on the therapeutic development for Seasonal Allergic Rhinitis & Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with latest updates, and special features...
CHICAGO, Dec. 21, 2012 /PRNewswire/ -- December is a time for wrapping up the year and wrapping up the fun. But if you're a chronic headache sufferer, putting on a happy holiday can be tough. Leading Chicago allergy doctor, Brian Rotskoff, MD, helps patients keep holiday headaches under control. It starts, he says, with learning what causes your migraine headaches or sinus headaches and what it takes to cross your headache threshold. Dr. Rostkoff's expertise includes the full range...
